Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty

Richard H White, Patrick S Romano, Hong Zhou, Juan Rodrigo, William Bargar

Research output: Contribution to journalArticle

464 Citations (Scopus)

Abstract

Background: Little is known about the incidence and time course of clinical thromboembolic events after total hip or knee arthroplasty, particularly after hospital discharge. Methods: We used a linked hospital discharge database provided by the State of California to identify cases diagnosed as having deep vein thrombosis or pulmonary embolism within 3 months of unilateral total hip or knee arthroplasty. Also, we surveyed orthopedic surgeons to estimate the frequency of postoperative thromboprophylaxis during July 1991 through June 1993. Medical charts were audited to determine the accuracy of the coded records. Results: Among 19586 primary hip and 24059 primary knee arthroplasties, the cumulative incidence of deep vein thrombosis or pulmonary embolism within 3 months of surgery was 556 (2.8%) after hip arthroplasty and 508 (2.1%) after knee arthroplasty. The diagnosis of thromboembolism was made after hospital discharge in 76% and 47% of the total hip and total knee arthroplasty cases, respectively (P<.001), with a median time of diagnosis of 17 days and 7 days after surgery, respectively (P<.001). Questionnaire results indicated that 95% of all cases received thromboprophylaxis and that the frequency, type, and duration of thromboprophylaxis was virtually identical after hip and knee arthroplasty. Conclusions: There is a difference in the temporal patterns of clinically symptomatic thromboembolic complications after total hip and total knee arthroplasty, suggesting differences in pathogenesis or natural history. The findings suggest that to further reduce thromboembolic outcomes, earlier, more intense prophylaxis may be needed for total knee arthroplasty, and more prolonged prophylaxis may be required after total hip arthroplasty.

Original languageEnglish (US)
Pages (from-to)1525-1531
Number of pages7
JournalArchives of Internal Medicine
Volume158
Issue number14
DOIs
StatePublished - 1998

Fingerprint

Knee Replacement Arthroplasties
Hip
Incidence
Pulmonary Embolism
Venous Thrombosis
Arthroplasty
Thromboembolism
Natural History
Ambulatory Surgical Procedures
Databases

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. / White, Richard H; Romano, Patrick S; Zhou, Hong; Rodrigo, Juan; Bargar, William.

In: Archives of Internal Medicine, Vol. 158, No. 14, 1998, p. 1525-1531.

Research output: Contribution to journalArticle

@article{73c45357668c47dc91ed99499349d209,
title = "Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty",
abstract = "Background: Little is known about the incidence and time course of clinical thromboembolic events after total hip or knee arthroplasty, particularly after hospital discharge. Methods: We used a linked hospital discharge database provided by the State of California to identify cases diagnosed as having deep vein thrombosis or pulmonary embolism within 3 months of unilateral total hip or knee arthroplasty. Also, we surveyed orthopedic surgeons to estimate the frequency of postoperative thromboprophylaxis during July 1991 through June 1993. Medical charts were audited to determine the accuracy of the coded records. Results: Among 19586 primary hip and 24059 primary knee arthroplasties, the cumulative incidence of deep vein thrombosis or pulmonary embolism within 3 months of surgery was 556 (2.8{\%}) after hip arthroplasty and 508 (2.1{\%}) after knee arthroplasty. The diagnosis of thromboembolism was made after hospital discharge in 76{\%} and 47{\%} of the total hip and total knee arthroplasty cases, respectively (P<.001), with a median time of diagnosis of 17 days and 7 days after surgery, respectively (P<.001). Questionnaire results indicated that 95{\%} of all cases received thromboprophylaxis and that the frequency, type, and duration of thromboprophylaxis was virtually identical after hip and knee arthroplasty. Conclusions: There is a difference in the temporal patterns of clinically symptomatic thromboembolic complications after total hip and total knee arthroplasty, suggesting differences in pathogenesis or natural history. The findings suggest that to further reduce thromboembolic outcomes, earlier, more intense prophylaxis may be needed for total knee arthroplasty, and more prolonged prophylaxis may be required after total hip arthroplasty.",
author = "White, {Richard H} and Romano, {Patrick S} and Hong Zhou and Juan Rodrigo and William Bargar",
year = "1998",
doi = "10.1001/archinte.158.14.1525",
language = "English (US)",
volume = "158",
pages = "1525--1531",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "14",

}

TY - JOUR

T1 - Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty

AU - White, Richard H

AU - Romano, Patrick S

AU - Zhou, Hong

AU - Rodrigo, Juan

AU - Bargar, William

PY - 1998

Y1 - 1998

N2 - Background: Little is known about the incidence and time course of clinical thromboembolic events after total hip or knee arthroplasty, particularly after hospital discharge. Methods: We used a linked hospital discharge database provided by the State of California to identify cases diagnosed as having deep vein thrombosis or pulmonary embolism within 3 months of unilateral total hip or knee arthroplasty. Also, we surveyed orthopedic surgeons to estimate the frequency of postoperative thromboprophylaxis during July 1991 through June 1993. Medical charts were audited to determine the accuracy of the coded records. Results: Among 19586 primary hip and 24059 primary knee arthroplasties, the cumulative incidence of deep vein thrombosis or pulmonary embolism within 3 months of surgery was 556 (2.8%) after hip arthroplasty and 508 (2.1%) after knee arthroplasty. The diagnosis of thromboembolism was made after hospital discharge in 76% and 47% of the total hip and total knee arthroplasty cases, respectively (P<.001), with a median time of diagnosis of 17 days and 7 days after surgery, respectively (P<.001). Questionnaire results indicated that 95% of all cases received thromboprophylaxis and that the frequency, type, and duration of thromboprophylaxis was virtually identical after hip and knee arthroplasty. Conclusions: There is a difference in the temporal patterns of clinically symptomatic thromboembolic complications after total hip and total knee arthroplasty, suggesting differences in pathogenesis or natural history. The findings suggest that to further reduce thromboembolic outcomes, earlier, more intense prophylaxis may be needed for total knee arthroplasty, and more prolonged prophylaxis may be required after total hip arthroplasty.

AB - Background: Little is known about the incidence and time course of clinical thromboembolic events after total hip or knee arthroplasty, particularly after hospital discharge. Methods: We used a linked hospital discharge database provided by the State of California to identify cases diagnosed as having deep vein thrombosis or pulmonary embolism within 3 months of unilateral total hip or knee arthroplasty. Also, we surveyed orthopedic surgeons to estimate the frequency of postoperative thromboprophylaxis during July 1991 through June 1993. Medical charts were audited to determine the accuracy of the coded records. Results: Among 19586 primary hip and 24059 primary knee arthroplasties, the cumulative incidence of deep vein thrombosis or pulmonary embolism within 3 months of surgery was 556 (2.8%) after hip arthroplasty and 508 (2.1%) after knee arthroplasty. The diagnosis of thromboembolism was made after hospital discharge in 76% and 47% of the total hip and total knee arthroplasty cases, respectively (P<.001), with a median time of diagnosis of 17 days and 7 days after surgery, respectively (P<.001). Questionnaire results indicated that 95% of all cases received thromboprophylaxis and that the frequency, type, and duration of thromboprophylaxis was virtually identical after hip and knee arthroplasty. Conclusions: There is a difference in the temporal patterns of clinically symptomatic thromboembolic complications after total hip and total knee arthroplasty, suggesting differences in pathogenesis or natural history. The findings suggest that to further reduce thromboembolic outcomes, earlier, more intense prophylaxis may be needed for total knee arthroplasty, and more prolonged prophylaxis may be required after total hip arthroplasty.

UR - http://www.scopus.com/inward/record.url?scp=0031851274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031851274&partnerID=8YFLogxK

U2 - 10.1001/archinte.158.14.1525

DO - 10.1001/archinte.158.14.1525

M3 - Article

C2 - 9679793

AN - SCOPUS:0031851274

VL - 158

SP - 1525

EP - 1531

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 14

ER -